bromodeoxyuridine has been researched along with melphalan in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Dozi-Vassiliades, J; Hatzitheodoridou, P; Koliouskas, DE; Kourakis, A; Mourelatos, D | 1 |
| Golomb, FM | 1 |
| Alikhanian, SI; Beglarian, DB; Oganesian, MG | 1 |
| D'Incalci, M; Erba, E; Mascellani, E; Pifferi, A | 1 |
| Cappella, P; Lupi, M; Matera, G; Natoli, C; Ubezio, P | 1 |
8 other study(ies) available for bromodeoxyuridine and melphalan
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Enhancement of cytogenetic damage by inhibitors of poly(ADP-ribose)polymerase in human lymphocytes exposed to antineoplastics in vivo and in vitro.
Topics: Benzamides; Bromodeoxyuridine; Cell Division; Colchicine; Drug Synergism; Humans; Kinetics; Lymphocytes; Melphalan; Mutagens; Poly(ADP-ribose) Polymerase Inhibitors; Sister Chromatid Exchange; Thiotepa | 1986 |
Perfusion and infusion chemotherapy for cancer of the head and neck.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carotid Arteries; Catheterization; Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Dactinomycin; DNA; Floxuridine; Fluorouracil; Head; Humans; Infusions, Parenteral; Melphalan; Methods; Neck; Nitrogen Mustard Compounds | 1964 |
[Comparative study of mutagenesis in amber mutants of bacteriophage T4].
Topics: Bromodeoxyuridine; Coliphages; Genetic Code; Hydroxylamines; Melphalan; Mutagens; Mutation; Nitrous Acid; Peptide Chain Termination, Translational; Purines | 1974 |
Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line.
Topics: Alkylating Agents; Bromodeoxyuridine; Cell Cycle; Distamycins; DNA; DNA, Neoplasm; Female; Flow Cytometry; Humans; In Vitro Techniques; Melphalan; Nitrogen Mustard Compounds; Nucleic Acid Conformation; Ovarian Neoplasms; Tumor Cells, Cultured | 1995 |
Interpreting cell cycle effects of drugs: the case of melphalan.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Bromodeoxyuridine; Cell Cycle; Cell Death; Cell Division; Cell Line, Tumor; Computer Simulation; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescein-5-isothiocyanate; G1 Phase; G2 Phase; Humans; In Situ Nick-End Labeling; Kinetics; Melphalan; S Phase; Time Factors | 2006 |